Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry

NCT02392078 is registered in ClinicalTrials.gov with Monteris Medical as lead sponsor.

NCT NCT02392078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Lead sponsor
Monteris Medical
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
September 30, 2023
Enrollment
1,153 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

epileptic/seizure foci, metastatic brain tumor, movement disorders, primary brain tumor